DGCI on Sunday (January 3) formally approved Serum Institute's Covishield and Bharat Biotech's Covaxin for use in India. ... Jan 04
Catalent and Astrazeneca partners for the Covid vaccine manufacturing... Aug 26
-Advertisements-